We use cookies for a better user experience. Read our Privacy Policy
I Agree
In-vitro Transcription Templates Market
The in-vitro transcription is a procedure that uses bacteriophage DNA-dependent RNA polymerase to synthesize RNA of any sequence from a DNA template. In-vitro transcription template reactions comprise an RNA polymerase promoter upstream of a series of interest. Synthesized RNA transcripts are further used for analyzing cellular RNA functionality in methods such as splicing, RNA processing, intracellular transport, viral infectivity, and translation. Advancements in biotechnology, including molecular biology and nanotechnology are significantly contributing to the expansion of the global in-vitro transcription templates market. The in-vitro transcription allows healthcare specialists to produce different sizes of RNA molecule ranging from milligram, microgram, and kilograms. Moreover, to perform multiple reactions to recognize biochemical processes of the human body, the formations of RNA molecules help researchers to identify it.
The in-vitro transcription templates market is witnessing massive investments in pharmaceutical and healthcare firms for research and development purposes. Research progresses in gene editing and drug formations required innovation and advanced transcription methods to study further, as these methods are utilized to introduce new drugs and results in the pharmaceutical industry. The increasing adoption of transcription methods to customize medications and drugs by healthcare providers is anticipating a surge in the demand for the in-vitro transcription templates market during the forecast period. Moreover, the rising prevalence of rare disorders, gene editing technology, and enabling targeted drugs with the use of RNA synthesis to stick to specific targets are some of the key factors contributing to the market growth in the upcoming future.
Request a sample to get extensive insights into the In-vitro Transcription Templates Market
The world continues to fight the disastrous effects of the ongoing COVID-19 pandemic. The extremely infectious nature of this respiratory condition hurdles high-level viral diagnostic technologies for speedy, scalable, affordable, and high precision testing. Molecular assays have been the gold criterion for immediate disclosure of the proximity of the viral RNA in suspected individuals. Moreover, immunoassays are being used in the examination of individuals by identifying antibodies against COVID-19. Improvements and developments in the biotechnology and pharmaceutical sectors are helping to produce the cure for COVID-19. The Messenger RNA or mRNA vaccines have secured the field with more agile production of new curative molecules. The rising necessity of Vitro transcriptions for the cure analysis of COVID-19 is increasing the demand for the in-vitro transcription templates market presently and is expected to further increase in the near future.
Vaccination producers such as Moderna presented their RNA vaccine candidate to NIAID for pre-clinical testing and launched a clinical trial by April 2020 with an immediate request to use models as a vaccine. The vaccine showed 95% effectiveness and excellent protection. Thus, following the research and hypothesis, the global in-vitro transcription templates market has grown resulting in rising production and distribution rate and increased efficiency and safety of the potential of mRNA therapy. Thus, the in-vitro transcription templates market is expanding even in the pandemic.
To understand how our report can bring difference to your business strategy, Ask for a brochure
The present medical trends are moving toward synthetic RNA platforms, which enable accelerated, measurable, and cell-free production of preventive and therapeutic vaccines. The in-vitro transcription of antigen-encoding sequences or immunotherapies as synthetic RNA transcripts are in the expanding pipeline with the rising worldwide investments for its effectiveness. In-vitro transcribed mRNAs encoding viral antigens have been treated as a cure, while those encoding curative proteins have been examined for immunotherapy. The procedure is proving useful for treating various other infectious and severe diseases. Moreover, innovations and development in the medical technology are aiding in improved efficiency and outcomes. However, the expensive pricing for in-vitro transcription templates is hindering the growth rate, mostly in developing countries. The increasing production rates and demand for the market are expected to lower the prices, making it convenient for developing nations. Hence, the in-vitro transcription templates market is anticipated to grow in the developing countries during the forecast period,
In-vitro transcription templates have been advanced and extensively used for several years to investigate the molecular mechanisms involved in transcription. Technological progress and procedures for targeting RNA include using the CRISPR-Cas9 genome editing technology, DNA-directed RNA intervention (ddRNAi) technology, and improved specific low molecular modulators for RNA or RNA-modifying enzymes. The recent years have witnessed new companies centering on the production of small-molecular RNA modulators. Applications of in-vitro transcription templates extend to multiple diseases, including neurological conditions and cancer. Emerging modifications and development are expected to provide alternative strategies to target RNA for drug development, which can result in propelling the global market. The global in-vitro transcription templates market is expected to expand at a CAGR of ~20% from 2021 to 2030.
The regional in-vitro transcription templates market is dominated by North America and currently holds the largest share. North America is expected to lead the future market, owing to the increase in demand for biopharmaceuticals such as vaccines and RNA-based therapeutics, peptides for the treatment of cancer, neurological diseases, and chronic kidney diseases. However, the demand for in-vitro transcription templates is expected to grow at a rapid pace due to rise in individual income, biotechnology, research institutes, and research funding by government and private bodies; expansion of healthcare infrastructure; large population base; and increase in the incidence of chronic and infectious diseases.
Stuck in a neck-to-neck competition with other brands? Request a custom report on In-vitro Transcription Templates Market
Analysts’ Viewpoint
In-vitro transcription helps researchers with the ability to synthesize RNA in the laboratory. The crucially important applications of in-vitro transcription templates for various infectious diseases, lifestyle diseases, genetic diseases, and others including cancer have tremendously driven the in-vitro transcription templates market. Investments by major businesses to sustain their position are likely to create significant opportunities in the market. Moreover, increasing adoption of technologically advanced products, rising patient population, and rapidly spreading of COVID-19 virus mutants are contributing to the growth of the global in-vitro transcription templates market. The heavy cost involved in the procedures is hindering the market growth in developing economies. However, due to rising government investments and influence of critical importance are helping in overcoming price barriers, resulting in a boost of the global in-vitro transcription templates market during the forecast period.
In-vitro Transcription Templates Market – Segmentation
| Disease |
|
| Treatment |
|
| Research Stage |
|
| End User |
|
| Region |
|
In-vitro transcription templates market to reach valuation of ~US$ 900 Mn by 2030
In-vitro transcription templates market is expected to expand at a CAGR of ~20% from 2021 to 2030
In-vitro transcription templates market is driven by increase in R&D funding in healthcare and biotechnology and rise in technological advancements in molecular biology
North America dominated the global in-vitro transcription templates market and the trend is likely to continue during the forecast period
Key players in the global in-vitro transcription templates market include Thermo Fisher Scientific, Inc., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Takara Bio Inc., Lucigen Corporation, Enzynomics Co. Ltd., Enzo Life Sciences, Inc. and Cytiva (Danaher)
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In-vitro Transcription Templates Market
4. Market Overview
4.1. Introduction
4.1.1. Disease Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In-vitro Transcription Templates Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Major Research Institutes Involved
5.3. Disease Prevalence & Incidence Rate globally with key countries
5.4. Number of mRNA Templates utilized Per Year
5.5. Analysis of Purchase Criteria (vaccine/therapeutics/research)
5.5.1. Overview of Purchase Criteria
5.5.2. mRNA Size Needs
5.5.3. Synthesis Scale Needs
5.5.4. Modified Bases Needs
5.5.5. cGMP/21 CFR part 11 certification requirement assessment
5.6. COVID-19 Pandemic Impact on Industry (value chain and short / mid /long term impact)
6. Global In-vitro Transcription Templates Market Analysis and Forecast, by Disease
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031
6.2.1. Cancer
6.2.1.1. Solid Tumors
6.2.1.2. Colorectal Cancer
6.2.1.3. NSCLC
6.2.1.4. Melanoma
6.2.1.5. Leukemia
6.2.1.6. Prostate Cancer
6.2.1.7. Others
6.2.2. Infectious Diseases
6.2.2.1. Influenza
6.2.2.2. COVID-19
6.2.2.3. AIDS
6.2.2.4. Others
6.2.3. Lifestyle Diseases
6.2.4. Genetic Diseases
6.2.5. Others
6.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease
7. Global In-vitro Transcription Templates Market Analysis and Forecast, by Treatment
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031
7.2.1. Vaccine
7.2.2. Therapeutic
7.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment
8. Global In-vitro Transcription Templates Market Analysis and Forecast, by Research Stage
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global In-vitro Transcription Templates Market Value Forecast by Research Stage, 2017–2031
8.2.1. Exploratory
8.2.2. Clinical
8.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage
9. Global In-vitro Transcription Templates Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.1.1. Key Findings / Developments
9.2. Global In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031
9.2.1. Pharmaceutical & Biotechnology Companies
9.2.2. CROs & CMOs
9.2.3. Academics & Research
9.2.4. Others
9.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by End-user
10. Global In-vitro Transcription Templates Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global In-vitro Transcription Templates Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Region
11. North America In-vitro Transcription Templates Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America In-vitro Transcription Templates Market Value Forecast by Disease, 2017–2031
11.2.1. Cancer
11.2.1.1. Solid Tumors
11.2.1.2. Colorectal Cancer
11.2.1.3. NSCLC
11.2.1.4. Melanoma
11.2.1.5. Leukemia
11.2.1.6. Prostate Cancer
11.2.1.7. Others
11.2.2. Infectious Diseases
11.2.2.1. Influenza
11.2.2.2. COVID-19
11.2.2.3. AIDS
11.2.2.4. Others
11.2.3. Lifestyle Diseases
11.2.4. Genetic Diseases
11.2.5. Others
11.3. North America In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031
11.3.1. Vaccine
11.3.2. Therapeutic
11.4. North America In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031
11.4.1. Exploratory
11.4.2. Clinical
11.5. North America In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031
11.5.1. Pharmaceutical & Biotechnology Companies
11.5.2. CROs & CMOs
11.5.3. Academics & Research
11.5.4. Others
11.6. North America In-vitro Transcription Templates Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. North America In-vitro Transcription Templates Market Attractiveness Analysis
11.7.1. By Disease
11.7.2. By Treatment
11.7.3. By Research Stage
11.7.4. By End-user
11.7.5. By Country
12. Europe In-vitro Transcription Templates Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031
12.2.1. Cancer
12.2.1.1. Solid Tumors
12.2.1.2. Colorectal Cancer
12.2.1.3. NSCLC
12.2.1.4. Melanoma
12.2.1.5. Leukemia
12.2.1.6. Prostate Cancer
12.2.1.7. Others
12.2.2. Infectious Diseases
12.2.2.1. Influenza
12.2.2.2. COVID-19
12.2.2.3. AIDS
12.2.2.4. Others
12.2.3. Lifestyle Diseases
12.2.4. Genetic Diseases
12.2.5. Others
12.3. Europe In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031
12.3.1. Vaccine
12.3.2. Therapeutic
12.4. Europe In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031
12.4.1. Exploratory
12.4.2. Clinical
12.5. Europe In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031
12.5.1. Pharmaceutical & Biotechnology Companies
12.5.2. CROs & CMOs
12.5.3. Academics & Research
12.5.4. Others
12.6. Europe In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Europe In-vitro Transcription Templates Market Attractiveness Analysis
12.7.1. By Disease
12.7.2. By Treatment
12.7.3. By Research Stage
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific In-vitro Transcription Templates Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031
13.2.1. Cancer
13.2.1.1. Solid Tumors
13.2.1.2. Colorectal Cancer
13.2.1.3. NSCLC
13.2.1.4. Melanoma
13.2.1.5. Leukemia
13.2.1.6. Prostate Cancer
13.2.1.7. Others
13.2.2. Infectious Diseases
13.2.2.1. Influenza
13.2.2.2. COVID-19
13.2.2.3. AIDS
13.2.2.4. Others
13.2.3. Lifestyle Diseases
13.2.4. Genetic Diseases
13.2.5. Others
13.3. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031
13.3.1. Vaccine
13.3.2. Therapeutic
13.4. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031
13.4.1. Exploratory
13.4.2. Clinical
13.5. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031
13.5.1. Pharmaceutical & Biotechnology Companies
13.5.2. CROs & CMOs
13.5.3. Academics & Research
13.5.4. Others
13.6. Asia Pacific In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis
13.7.1. By Disease
13.7.2. By Treatment
13.7.3. By Research Stage
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America In-vitro Transcription Templates Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031
14.2.1. Cancer
14.2.1.1. Solid Tumors
14.2.1.2. Colorectal Cancer
14.2.1.3. NSCLC
14.2.1.4. Melanoma
14.2.1.5. Leukemia
14.2.1.6. Prostate Cancer
14.2.1.7. Others
14.2.2. Infectious Diseases
14.2.2.1. Influenza
14.2.2.2. COVID-19
14.2.2.3. AIDS
14.2.2.4. Others
14.2.3. Lifestyle Diseases
14.2.4. Genetic Diseases
14.2.5. Others
14.3. Latin America In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031
14.3.1. Vaccine
14.3.2. Therapeutic
14.4. Latin America In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031
14.4.1. Exploratory
14.4.2. Clinical
14.5. Latin America In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031
14.5.1. Pharmaceutical & Biotechnology Companies
14.5.2. CROs & CMOs
14.5.3. Academics & Research
14.5.4. Others
14.6. Latin America In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America In-vitro Transcription Templates Market Attractiveness Analysis
14.7.1. By Disease
14.7.2. By Treatment
14.7.3. By Research Stage
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa In-vitro Transcription Templates Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Disease, 2017–2031
15.2.1. Cancer
15.2.1.1. Solid Tumors
15.2.1.2. Colorectal Cancer
15.2.1.3. NSCLC
15.2.1.4. Melanoma
15.2.1.5. Leukemia
15.2.1.6. Prostate Cancer
15.2.1.7. Others
15.2.2. Infectious Diseases
15.2.2.1. Influenza
15.2.2.2. COVID-19
15.2.2.3. AIDS
15.2.2.4. Others
15.2.3. Lifestyle Diseases
15.2.4. Genetic Diseases
15.2.5. Others
15.3. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Treatment, 2017–2031
15.3.1. Vaccine
15.3.2. Therapeutic
15.4. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Research Stage, 2017–2031
15.4.1. Exploratory
15.4.2. Clinical
15.5. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by End-user, 2017–2031
15.5.1. Pharmaceutical & Biotechnology Companies
15.5.2. CROs & CMOs
15.5.3. Academics & Research
15.5.4. Others
15.6. Middle East & Africa In-vitro Transcription Templates Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis
15.7.1. By Disease
15.7.2. By Treatment
15.7.3. By Research Stage
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis by Company, 2020
16.3. Company Profiles
16.3.1. Thermo Fisher Scientific, Inc.
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Promega Corporation
16.3.2.1. Company Overview
16.3.2.2. Growth Strategies
16.3.2.3. SWOT Analysis
16.3.3. Agilent Technologies, Inc.
16.3.3.1. Company Overview
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. New England Biolabs
16.3.4.1. Company Overview
16.3.4.2. Growth Strategies
16.3.4.3. SWOT Analysis
16.3.5. Takara Bio Inc.
16.3.5.1. Company Overview
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Lucigen Corporation
16.3.6.1. Company Overview
16.3.6.2. SWOT Analysis
16.3.7. Enzynomics Co. Ltd.
16.3.7.1. Company Overview
16.3.7.2. SWOT Analysis
16.3.8. Enzo Life Sciences, Inc.
16.3.8.1. Company Overview
16.3.8.2. SWOT Analysis
16.3.9. Cytiva (Danaher)
16.3.9.1. Company Overview
16.3.9.2. Company Financials
16.3.9.3. Growth Strategies
16.3.9.4. SWOT Analysis
List of Table
Table 01: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031
Table 02: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 03: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017–2031
Table 04: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 05: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031
Table 06: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 08: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031
Table 10: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 11: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017–2031
Table 12: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 13: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031
Table 14: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031
Table 17: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 18: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017–2031
Table 19: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 20: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031
Table 21: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 22: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 23: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031
Table 24: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 25: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017–2031
Table 26: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 27: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031
Table 28: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 29: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 30: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031
Table 31: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 32: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious diseases, 2017–2031
Table 33: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 34: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031
Table 35: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 36: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 37: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Disease, 2017–2031
Table 38: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Cancer, 2017–2031
Table 39: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017–2031
Table 40: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Treatment, 2017–2031
Table 41: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by Research Stage, 2017–2031
Table 42: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figure
Figure 01: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global In-vitro Transcription Templates Market Value Share, by Disease, 2020
Figure 03: Global In-vitro Transcription Templates Market Value Share, by Extraction Type, 2020
Figure 04: Global In-vitro Transcription Templates Market Value Share, by Method, 2020
Figure 05: Global In-vitro Transcription Templates Market Value Share, by End-user, 2020
Figure 06: Global In-vitro Transcription Templates Market Value Share, by Region, 2020
Figure 07: Global In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 08: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031
Figure 09: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Cancer, 2017–2031
Figure 10: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Infectious Diseases, 2017–2031
Figure 11: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Lifestyle Diseases, 2017–2031
Figure 12: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Genetic Diseases, 2017–2031
Figure 13: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Others, 2017–2031
Figure 14: Global In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 15: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 16: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Vaccine, 2017–2031
Figure 17: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Therapeutic, 2017–2031
Figure 18: Global In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 19: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031
Figure 20: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Exploratory, 2017–2031
Figure 21: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Clinical, 2017–2031
Figure 22: Global In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 23: Global In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031
Figure 24: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031
Figure 25: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by CROs & CMOs, 2017–2031
Figure 26: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Academics & Research, 2017–2031
Figure 27: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Others, 2017–2031
Figure 28: Global In-vitro Transcription Templates Market Value Share Analysis, by Region, 2020 and 2031
Figure 29: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Region, 2021–2031
Figure 30: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031
Figure 31: North America In-vitro Transcription Templates Market Value Share Analysis, by Country, 2020 and 2031
Figure 32: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Country, 2021–2031
Figure 33: North America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 34: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031
Figure 35: North America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 36: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 37: North America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 38: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031
Figure 39: North America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 40: North America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031
Figure 41: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031
Figure 42: Europe In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 43: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 44: Europe In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 45: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031
Figure 46: Europe In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 47: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 48: Europe In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 49: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031
Figure 50: Europe In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 51: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031
Figure 52: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031
Figure 53: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 54: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 55: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 56: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031
Figure 57: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 58: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 59: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 60: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031
Figure 61: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 62: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031
Figure 63: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031
Figure 64: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 65: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 66: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 67: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031
Figure 68: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 69: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 70: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 71: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031
Figure 72: Latin America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 73: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031
Figure 74: Middle East & Africa In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017–2031
Figure 75: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 76: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 77: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2020 and 2031
Figure 78: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2021–2031
Figure 79: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 80: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 81: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2020 and 2031
Figure 82: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2021–2031
Figure 83: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2020 and 2031
Figure 84: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes